- Home
- PMCB vs ATIF Comparison
PMCB vs ATIF Comparison
Compare PMCB & ATIF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMCB
- ATIF
- Stock Information
- Founded
- PMCB 1996
- ATIF 2015
- Country
- PMCB United States
- ATIF United States
- Employees
- PMCB N/A
- ATIF N/A
- Industry
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- ATIF Professional Services
- Sector
- PMCB Health Care
- ATIF Consumer Discretionary
- Exchange
- PMCB Nasdaq
- ATIF Nasdaq
- Market Cap
- PMCB 15.8M
- ATIF 12.6M
- IPO Year
- PMCB N/A
- ATIF 2019
- Fundamental
- Price
- PMCB $1.80
- ATIF $0.86
- Analyst Decision
- PMCB
- ATIF
- Analyst Count
- PMCB 0
- ATIF 0
- Target Price
- PMCB N/A
- ATIF N/A
- AVG Volume (30 Days)
- PMCB 37.3K
- ATIF 7.1K
- Earning Date
- PMCB 09-17-2024
- ATIF 11-11-2024
- Dividend Yield
- PMCB N/A
- ATIF N/A
- EPS Growth
- PMCB N/A
- ATIF N/A
- EPS
- PMCB 0.54
- ATIF N/A
- Revenue
- PMCB N/A
- ATIF $500,000.00
- Revenue This Year
- PMCB N/A
- ATIF N/A
- Revenue Next Year
- PMCB N/A
- ATIF N/A
- P/E Ratio
- PMCB $3.29
- ATIF N/A
- Revenue Growth
- PMCB N/A
- ATIF N/A
- 52 Week Low
- PMCB $1.39
- ATIF $0.58
- 52 Week High
- PMCB $2.58
- ATIF $1.45
- Technical
- Relative Strength Index (RSI)
- PMCB 50.47
- ATIF 44.76
- Support Level
- PMCB $1.72
- ATIF $0.80
- Resistance Level
- PMCB $1.95
- ATIF $1.12
- Average True Range (ATR)
- PMCB 0.23
- ATIF 0.16
- MACD
- PMCB -0.01
- ATIF -0.03
- Stochastic Oscillator
- PMCB 48.33
- ATIF 22.58
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
About ATIF ATIF Holdings Limited
ATIF Holdings Ltd is a consulting company. It provides financial and advisory services to small and medium-sized enterprises and also to individual customers and families. The firm also offers Pre-IPO's, and Post-IPO's services. It operates in one operating segment which is the consulting service business. It generates the majority of its revenue from the USA.